These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 18442908)

  • 1. Design and synthesis of N-alkyl oxindolylidene acetic acids as a new class of potent Cdc25A inhibitors.
    Shimazawa R; Kuriyama M; Shirai R
    Bioorg Med Chem Lett; 2008 Jun; 18(11):3350-3. PubMed ID: 18442908
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel CDC25A phosphatase inhibitors from pyrolysis of 3-alpha-azido-B-homo-6-oxa-4-cholesten-7-one on silica gel.
    Peng H; Zalkow LH; Abraham RT; Powis G
    J Med Chem; 1998 Nov; 41(24):4677-80. PubMed ID: 9822537
    [No Abstract]   [Full Text] [Related]  

  • 3. Novel, highly potent aldose reductase inhibitors: cyano(2-oxo-2,3-dihydroindol-3-yl)acetic acid derivatives.
    Da Settimo F; Primofiore G; Da Settimo A; La Motta C; Simorini F; Novellino E; Greco G; Lavecchia A; Boldrini E
    J Med Chem; 2003 Apr; 46(8):1419-28. PubMed ID: 12672241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of Cdc25 phosphatases by indolyldihydroxyquinones.
    Sohn J; Kiburz B; Li Z; Deng L; Safi A; Pirrung MC; Rudolph J
    J Med Chem; 2003 Jun; 46(13):2580-8. PubMed ID: 12801222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis of the naphthalene-derived inhibitors against Cdc25A dual-specificity protein phosphatase and their biological activity.
    Shimbashi A; Tsuchiya A; Imoto M; Nishiyama S
    Bioorg Med Chem Lett; 2005 Jan; 15(1):61-5. PubMed ID: 15582411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design and synthesis of novel Cdc25A-inhibitors having phosphate group as a hydrophilic residue.
    Shimazawa R; Gochomori M; Shirai R
    Bioorg Med Chem Lett; 2004 Aug; 14(16):4339-42. PubMed ID: 15261298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and biological evaluation of dialkylsubstituted maleic anhydrides as novel inhibitors of Cdc25 dual specificity phosphatases.
    Brault L; Denancé M; Banaszak E; El Maadidi S; Battaglia E; Bagrel D; Samadi M
    Eur J Med Chem; 2007 Feb; 42(2):243-7. PubMed ID: 17084000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design and synthesis of benzoxazole containing indole analogs as peroxisome proliferator-activated receptor-γ/δ dual agonists.
    Gim HJ; Cheon YJ; Ryu JH; Jeon R
    Bioorg Med Chem Lett; 2011 May; 21(10):3057-61. PubMed ID: 21482466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design and synthesis of dysidiolide analogs from vitamin D3: novel class of Cdc25A inhibitors.
    Shimazawa R; Suzuki T; Dodo K; Shirai R
    Bioorg Med Chem Lett; 2004 Jun; 14(12):3291-4. PubMed ID: 15149692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design and synthesis of macrocyclic inhibitors of phosphatase cdc25B.
    Bäurle S; Blume T; Günther J; Henschel D; Hillig RC; Husemann M; Mengel A; Parchmann C; Schmid E; Skuballa W
    Bioorg Med Chem Lett; 2004 Apr; 14(7):1673-7. PubMed ID: 15026048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design, synthesis, and biological evaluation of novel (1-thioxo-1,2,3,4-tetrahydro-β-carbolin-9-yl)acetic acids as selective inhibitors for AKR1B1.
    Minehira D; Takeda D; Urata H; Kato A; Adachi I; Wang X; Matsuya Y; Sugimoto K; Takemura M; Endo S; Matsunaga T; Hara A; Koseki J; Narukawa K; Hirono S; Toyooka N
    Bioorg Med Chem; 2012 Jan; 20(1):356-67. PubMed ID: 22104435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery of novel Cdc25 phosphatase inhibitors with micromolar activity based on the structure-based virtual screening.
    Park H; Bahn YJ; Jung SK; Jeong DG; Lee SH; Seo I; Yoon TS; Kim SJ; Ryu SE
    J Med Chem; 2008 Sep; 51(18):5533-41. PubMed ID: 18714978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel naphthoquinone and quinolinedione inhibitors of CDC25 phosphatase activity with antiproliferative properties.
    Braud E; Goddard ML; Kolb S; Brun MP; Mondésert O; Quaranta M; Gresh N; Ducommun B; Garbay C
    Bioorg Med Chem; 2008 Oct; 16(19):9040-9. PubMed ID: 18789703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-based de novo design and biochemical evaluation of novel Cdc25 phosphatase inhibitors.
    Park H; Bahn YJ; Ryu SE
    Bioorg Med Chem Lett; 2009 Aug; 19(15):4330-4. PubMed ID: 19497739
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and biological evaluation of 4-fluoroproline and 4-fluoropyrrolidine-2-acetic acid derivatives as new GABA uptake inhibitors.
    Zhuang W; Zhao X; Zhao G; Guo L; Lian Y; Zhou J; Fang D
    Bioorg Med Chem; 2009 Sep; 17(18):6540-6. PubMed ID: 19703775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design and synthesis of potent and selective azaindole-based Rho kinase (ROCK) inhibitors.
    Schirok H; Kast R; Figueroa-Pérez S; Bennabi S; Gnoth MJ; Feurer A; Heckroth H; Thutewohl M; Paulsen H; Knorr A; Hütter J; Lobell M; Münter K; Geiss V; Ehmke H; Lang D; Radtke M; Mittendorf J; Stasch JP
    ChemMedChem; 2008 Dec; 3(12):1893-904. PubMed ID: 18973168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 4-Phenyl-7-azaindoles as potent and selective IKK2 inhibitors.
    Liddle J; Bamborough P; Barker MD; Campos S; Cousins RP; Cutler GJ; Hobbs H; Holmes DS; Ioannou C; Mellor GW; Morse MA; Payne JJ; Pritchard JM; Smith KJ; Tape DT; Whitworth C; Williamson RA
    Bioorg Med Chem Lett; 2009 May; 19(9):2504-8. PubMed ID: 19349179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and activity of 1-(3-amino-1-phenylpropyl)indolin-2-ones: a new class of selective norepinephrine reuptake inhibitors.
    McComas CC; Vu AT; Mahaney PE; Cohn ST; Fensome A; Marella MA; Nogle L; Trybulski EJ; Ye F; Zhang P; Alfinito P; Bray J; Johnston G; Koury E; Deecher DC
    Bioorg Med Chem Lett; 2008 Sep; 18(18):4929-31. PubMed ID: 18771916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Switching between agonists and antagonists at CRTh2 in a series of highly potent and selective biaryl phenoxyacetic acids.
    Luker T; Bonnert R; Schmidt J; Sargent C; Paine SW; Thom S; Pairaudeau G; Patel A; Mohammed R; Akam E; Dougall I; Davis AM; Abbott P; Brough S; Millichip I; McInally T
    Bioorg Med Chem Lett; 2011 Jun; 21(12):3616-21. PubMed ID: 21592791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exploring structural requirements for aldose-reductase inhibition by 2,4-dioxo-5-(naphth-2-ylmethylene)-3-thiazolidinyl acetic acids and 2-thioxo analogues: Fujita-Ban and Hansch approach.
    Soni LK; Kaskhedikar SG
    Arch Pharm (Weinheim); 2006 Jun; 339(6):327-31. PubMed ID: 16622827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.